Evidence map›Paper›PMID 24958849›Full record

ArticleThe Journal of experimental medicine2014

Proapoptotic Bim regulates antigen-specific NK cell contraction and the generation of the memory NK cell pool after cytomegalovirus infection.

Gundula Min-Oo, Natalie A Bezman, Sharline Madera, Joseph C Sun, Lewis L Lanier

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Nanomaterials Trigger Functional Anti-Tumoral Responses in Primary Human Immune Cells.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Virus-specific NK cell memory.The Journal of experimental medicine · 2021
    Review
  17. Article
  18. Article
  19. Molecular Regulation of NK Cell Maturation.Frontiers in immunology · 2020
    Review
  20. Deciphering Natural Killer Cell Homeostasis.Frontiers in immunology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Gundula Min-OoDepartment of Microbiology and Immunology and Cancer Research Institute, University of California, San Francisco, San Francisco, CA 94143.
Natalie A BezmanDepartment of Microbiology and Immunology and Cancer Research Institute, University of California, San Francisco, San Francisco, CA 94143.
Sharline MaderaImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
Joseph C SunImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
Lewis L LanierDepartment of Microbiology and Immunology and Cancer Research Institute, University of California, San Francisco, San Francisco, CA 94143Department of Microbiology and Immunology and Cancer Research Institute, University of California, San Francisco, San Francisco, CA 94143 Lewis.Lanier@ucsf.edu.
Cancer Research Institute · USMemorial Sloan Kettering Cancer Center · USUniversity of California, San Francisco · US

Funding

Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
UCSF Liver Core CenterP30DK026743 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Holger Willenbring · 1986 to 2026
$30.7M
MOLECULAR AND CELLULAR IMMUNOLOGYT32AI007334 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CYSTER, JASON G · 1988 to 2023
$11.0M
The natural killer cell response against mouse cytomegalovirus infectionR01AI100874 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI Joseph Chai-Yuen Sun · 2012 to 2026
$7.4M
NK MemoryR01AI068129 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LANIER, LEWIS LEE · 2006 to 2020
$6.0M
Natural killer cell responses against viral infectionR00AI085034 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI SUN, JOSEPH CHAI-YUEN · 2010 to 2011
$498k
NIAID NIH HHS AI068129NIAID NIH HHS AI085034NIAID NIH HHS AI100874NIAID NIH HHS R00 AI085034NIAID NIH HHS R01 AI068129NIAID NIH HHS R01 AI100874NIAID NIH HHS T32 AI007334NIDDK NIH HHS P30 DK026743NIGMS NIH HHS T32 GM007739
6 · The paper itself

Abstract

Apoptosis is critical for the elimination of activated lymphocytes after viral infection. Proapoptotic factor Bim (Bcl2l11) controls T lymphocyte contraction and the formation of memory T cells after infection. Natural killer (NK) cells also undergo antigen-driven expansion to become long-lived memory cells after mouse cytomegalovirus (MCMV) infection; therefore, we examined the role of Bim in regulating the MCMV-driven memory NK cell pool. Despite responding similarly early after infection, Bcl2l11(-/-) Ly49H(+) NK cells show impaired contraction and significantly outnumber wild-type (WT) cells after the expansion phase. The inability to reduce the effector pool leads to a larger Bcl2l11(-/-) NK memory subset, which displays a less mature phenotype (CD11b(lo), CD27(+)) and lower levels of NK cell memory-associated markers KLRG1 and Ly6C. Bcl2l11(-/-) memory NK cells demonstrate a reduced response to m157-mediated stimulation and do not protect as effectively as WT memory NK cells in an MCMV challenge model. Thus, Bim-mediated apoptosis drives selective contraction of effector NK cells to generate a pool of mature, MCMV-specific memory cells.

Indexed as

Immunologic MemoryAnimalsAntigens, DifferentiationAntigens, ViralApoptosisApoptosis Regulatory ProteinsBcl-2-Like Protein 11Herpesviridae InfectionsKiller Cells, NaturalMembrane ProteinsMiceMice, KnockoutMuromegalovirusProto-Oncogene ProteinsAntigens, DifferentiationAntigens, ViralApoptosis Regulatory ProteinsBcl2l11 protein, mouseBcl-2-Like Protein 11Membrane ProteinsProto-Oncogene Proteins

Identifiers

PMID24958849
PMCPMC4076589
OpenAlexW2144836713

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.